DENTSPLY SIRONA (XRAY) Proxy filing summary

Executive summary

• The 2026 annual meeting will be held virtually on June 2, 2026, with voting open to shareholders of record as of April 6, 2026.

• Four key proposals are up for vote: election of 12 directors, ratification of Deloitte as auditor, advisory approval of 2025 executive compensation, and approval of an amendment to increase shares under the 2024 Omnibus Incentive Plan by 15 million.

• The Board recommends voting FOR all proposals.

• The proxy statement includes detailed information on governance, compensation, risk oversight, and sustainability initiatives.

Voting matters and shareholder proposals

• Shareholders will vote on electing 12 director nominees, ratifying Deloitte as auditor, approving 2025 executive compensation (say-on-pay), and increasing shares under the 2024 Plan.

• Board recommends FOR all proposals.

• Shareholders may submit proposals for the 2027 meeting by December 24, 2026.

Board of directors and corporate governance

• Board consists of 12 nominees, 92% independent, with an average age of 64 and average tenure of 3.6 years.

• Board committees: Audit and Finance, Compensation & Human Capital, Corporate Governance and Nominating, Science and Technology.

• All committees are composed of independent directors.

• Board leadership is separated between a non-executive chairman and CEO.

• Directors are subject to stock ownership guidelines and annual performance assessments.